Oscar Health, Inc. (OSCR) 10-Year Financial Performance & Capital Metrics

OSCR • • Insurance & Managed Care

HealthcareHealth InsuranceMedicare Advantage SpecialistsTech-Enabled Medicare Advantage

AboutOscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.Show more

Revenue $9.18B +56.5%
Combined Ratio 99.64% -4.7%
Net Income $25M +109.4%
Return on Equity 2.79% +108.8%
Medical Cost Ratio 0%
Operating Margin 0.36% +108.0%
Net Margin 0.28% +106.0%
ROA 0.6% +109.0%
Equity / Assets 21% -6.2%
Book Value per Share 3.82 +5.1%
Tangible BV/Share 3.82 +5.1%
Debt/Equity 0.29 -20.5%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong Piotroski F-Score: 7/9

✗Weaknesses

✗Shares diluted 19.9% in last year

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y75.34%

3Y68.43%

TTM37.38%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-943.16%

EPS CAGR

10Y-

5Y-

3Y-

TTM-1020%

ROCE

10Y Avg-27.72%

5Y Avg-27.72%

3Y Avg-31.93%

Latest3.19%

Peer Comparison

Tech-Enabled Medicare Advantage

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
OSCROscar Health, Inc.	4.38B	17.38	181.61	56.54%	-2.16%	-23.77%	21.67%	0.29
CLOVClover Health Investments, Corp.	1.08B	2.54	-28.93	8.77%	-3.29%	-17.11%	3.09%
ALHCAlignment Healthcare, Inc.	4.19B	20.92	-31.22	48.25%	-0.57%	-12.86%		3.26

Profit & Loss

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Revenue+	553.78M	589.64M	1.92B	4.13B	5.86B	9.18B
Revenue Growth %	-	0.06%	2.26%	1.15%	0.42%	0.57%
Medical Costs & Claims+	0	0	0	0	0	0
Medical Cost Ratio %	-	-	-	-	-	-
Gross Profit+	553.78M	589.64M	1.92B	4.13B	5.86B	9.18B
Gross Margin %	-	-	-	-	-	-
Gross Profit Growth %	-	0.06%	2.26%	1.15%	0.42%	0.57%
Operating Expenses+	813.17M	995.42M	2.49B	4.74B	6.13B	9.14B
OpEx / Revenue %	-	-	-	-	-	-
Depreciation & Amortization	6.9M	11.29M	14.61M	15.28M	30.69M	32.15M
Combined Ratio %	-	-	-	-	-	-
Operating Income+	-259.39M	-405.78M	-570.58M	-610.08M	-267.3M	33.43M
Operating Margin %	-	-	-	-	-	-
Operating Income Growth %	-	-0.56%	-0.41%	-0.07%	0.56%	1.13%
EBITDA+	-252.49M	-394.5M	-555.98M	-594.79M	-236.61M	65.57M
EBITDA Margin %	-	-	-	-	-	-
Interest Expense	0	3.51M	4.72M	22.62M	24.6M	23.73M
Non-Operating Income	0	-3.51M	-4.72M	-22.62M	-24.6M	-23.73M
Pretax Income+	-259.39M	-405.78M	-570.58M	-610.08M	-267.3M	33.43M
Pretax Margin %	-	-	-	-	-	-
Income Tax+	1.79M	1.04M	846K	-523K	3.29M	7.3M
Effective Tax Rate %	-	-	-	-	-	-
Net Income+	-261.18M	-406.82M	-572.61M	-606.27M	-270.73M	25.43M
Net Margin %	-	-	-	-	-	-
Net Income Growth %	-	-0.56%	-0.41%	-0.06%	0.55%	1.09%
EPS (Diluted)+	-1.09	-1.70	-3.19	-2.87	-1.22	0.10
EPS Growth %	-	-0.56%	-0.88%	0.1%	0.57%	1.08%
EPS (Basic)	-8.93	-1.70	-3.19	-2.87	-1.22	0.11
Diluted Shares Outstanding	239.31M	239.31M	178.97M	212.47M	221.66M	265.85M

Balance Sheet

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Assets+	1.35B	2.27B	3.32B	4.53B	3.6B	4.84B
Asset Growth %	-	0.69%	0.46%	0.36%	-0.2%	0.34%
Total Investment Assets+	363.23M	692.13M	1.43B	2.79B	1.06B	2.44B
Long-Term Investments	333.75M	366.39M	587.09M	1.4B	689.83M	1.82B
Short-Term Investments	333.75M	366.39M	587.09M	1.4B	689.83M	624.46M
Total Current Assets+	0	0	0	4.12B	0	2.85B
Cash & Equivalents	336.64M	826.33M	1.1B	1.56B	1.87B	1.53B
Receivables	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Assets	-725.59M	-1.29B	-2.3B	1.12B	-3.05B	377.64M
Goodwill & Intangibles+	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	0
PP&E (Net)	33.08M	35.81M	46.61M	59.89M	61.93M	66.79M
Other Assets	-366.83M	-402.2M	-633.7M	-1.05B	-751.76M	113.28M
Total Liabilities	2.29B	3.57B	1.93B	3.63B	2.8B	3.82B
Total Debt+	0	142.49M	0	298M	298.78M	299.56M
Net Debt	-336.64M	-683.84M	-1.1B	-1.26B	-1.57B	-1.23B
Long-Term Debt	0	142.49M	0	298M	298.78M	299.56M
Short-Term Debt	0	0	0	0	0	0
Total Current Liabilities+	0	0	0	3.26B	0	3.17B
Accounts Payable	589.07M	655.23M	718.81M	1.37B	1.03B	1.4B
Deferred Revenue	0	0	0	0	0	0
Other Current Liabilities	-887.7M	-1.37B	-1.51B	381.05M	-2.08B	215.28M
Deferred Taxes	0	0	0	0	0	0
Other Liabilities	0	-142.49M	0	72.28M	-298.78M	61.28M
Total Equity+	-945.14M	-1.3B	1.39B	892.4M	806.12M	1.02B
Equity Growth %	-	-0.37%	2.07%	-0.36%	-0.1%	0.26%
Shareholders Equity	-945.14M	-1.3B	1.39B	890.38M	803.97M	1.01B
Minority Interest	0	0	5.29M	2.02M	2.15M	2.84M
Retained Earnings	-1.01B	-1.43B	-2B	-2.61B	-2.88B	-2.85B
Common Stock	2K	2K	2K	2K	2K	2K
Accumulated OCI	-27K	879K	-3.67M	-9.71M	1.31M	-1.83M
Return on Equity (ROE)	-	-	-11.85%	-0.53%	-0.32%	0.03%
Return on Assets (ROA)	-0.19%	-0.22%	-0.2%	-0.15%	-0.07%	0.01%
Equity / Assets	-	-	-	-	-	-
Debt / Equity	-	-	-	0.33x	0.37x	0.29x
Book Value per Share	-3.95	-5.42	7.78	4.20	3.64	3.82
Tangible BV per Share	-	-	-	-	-	-

Cash Flow

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-165.37M	222.73M	-181.75M	380.35M	-272.16M	978.19M
Operating CF Growth %	-	2.35%	-1.82%	3.09%	-1.72%	4.59%
Operating CF / Revenue %	-	-	-	-	-	-
Net Income	-261.18M	-406.82M	-571.43M	-609.55M	-270.59M	26.12M
Depreciation & Amortization	6.9M	11.29M	14.61M	15.28M	30.69M	32.15M
Stock-Based Compensation	33.56M	35.87M	86.3M	112.33M	159.68M	109.82M
Deferred Taxes	-426K	-67K	-101K	-165K	58K	-2.34M
Other Non-Cash Items	-6.43M	6.77M	41.19M	7.46M	86K	-26.42M
Working Capital Changes	62.21M	575.7M	247.7M	855M	-192.09M	838.86M
Cash from Investing+	150.51M	-344.71M	-774.51M	-226.52M	577.19M	-1.39B
Capital Expenditures	-26M	-14.02M	-25.89M	-29.01M	-25.58M	-27.9M
Acquisitions	0	0	7.23M	0	0	0
Purchase of Investments	-877.67M	-1B	-1.81B	-1.19B	-836.98M	-2.13B
Sale/Maturity of Investments	1000K	1000K	1000K	1000K	1000K	1000K
Other Investing	-7.08M	-1.24M	-555K	1.12M	-2.28M	3.93M
Cash from Financing+	-2.12M	611.71M	1.24B	301.11M	6.45M	68.39M
Dividends Paid	0	0	0	0	0	0
Share Repurchases	-2.99M	0	0	0	0	0
Stock Issued	0	0	1.35B	0	0	68.39M
Debt Issuance (Net)	0	1000K	-1000K	1000K	0	0
Other Financing	873K	89.04M	43.56M	-3.89M	6.45M	0
Net Change in Cash+	-16.98M	489.73M	282.45M	454.94M	311.47M	-340.85M
Exchange Rate Effect	0	0	0	0	0	0
Cash at Beginning	370.36M	353.38M	843.11M	1.13B	1.58B	1.89B
Cash at End	353.38M	843.11M	1.13B	1.58B	1.89B	1.55B
Free Cash Flow+	-191.37M	208.71M	-207.63M	351.34M	-297.74M	950.3M
FCF Growth %	-	2.09%	-1.99%	2.69%	-1.85%	4.19%
FCF Margin %	-	-	-	-	-	-
FCF per Share	-0.8	0.87	-1.16	1.65	-1.34	3.57

Key Ratios

Metric	2019	2020	2021	2022	2023	2024
Combined Ratio	146.84%	168.82%	129.7%	114.79%	104.56%	99.64%
Medical Cost Ratio	0%	0%	0%	0%	0%	0%
Return on Equity (ROE)	-	-	-1185.16%	-53.07%	-31.88%	2.79%
Return on Assets (ROA)	-19.39%	-22.48%	-20.47%	-15.45%	-6.66%	0.6%
Equity / Assets	-70.17%	-57.03%	41.92%	19.71%	22.38%	21%
Book Value / Share	-3.95	-5.42	7.78	4.2	3.64	3.82
Debt / Equity	-	-	-	0.33x	0.37x	0.29x
Revenue Growth	-	6.48%	225.78%	114.77%	42.11%	56.54%

Frequently Asked Questions

Valuation & Price

Oscar Health, Inc. (OSCR) has a price-to-earnings (P/E) ratio of 181.6x. This suggests investors expect higher future growth.

Growth & Financials

Oscar Health, Inc. (OSCR) grew revenue by 56.5% over the past year. This is strong growth.

Oscar Health, Inc. (OSCR) reported a net loss of $244.1M for fiscal year 2024.

Dividend & Returns

Oscar Health, Inc. (OSCR) has a return on equity (ROE) of 2.8%. This is below average, suggesting room for improvement.

Industry Metrics

Oscar Health, Inc. (OSCR) has a combined ratio of 0.0%. A ratio below 100% indicates underwriting profitability.

← Back to Screener